Deep dive: How AI reshapes the preclinical CRO model
LeoTZ03 · x · 2026-08-25
The article analyzes the structural challenges of traditional Contract Research Organizations (CROs), highlighting thin margins and a lack of upside capture. It proposes a 'Neo-CRO' model where AI-native TechBio companies rebuild the model using platforms, shifting from running assays to selling judgment, de-risking capabilities, and scientific intelligence rather than just cutting costs.
More from Venture
- Decentralized AI: Bittensor Battles for AI Ownership Against Big Tech — bittingthembits · 2026-08-25
- a16z: How AI Shifts Startups from Engineering-Bound to Capital-Bound — a16z · 2026-08-25
- ClickHouse tops $350M ARR; OpenAI usage up 10x in circular AI financing — iamKierraD · 2026-08-25
- After nearly six years without PMF, OpenBB shuts down and open-sources its entire product suite — mdancho84 · 2026-08-25
- From tokenmaxxing to budget caps: the two token economics of enterprise AI — WhatTheLJW · 2026-08-25
- KeenableAI raises $26M Seed for AI-native knowledge index — dchaplot · 2026-08-25